Dr. Ilana Goldberg joined the NIH in 2019 as a AAAS Science & Technology Policy Fellow at the National Institute of Biomedical Imaging and Bioengineering (NIBIB). She served as a Program Director and had oversight of the small business portfolio and entrepreneur training program, C3i. In addition, she is a project manager for the RADx Tech initiative and started a Technology for Maternal Health Initiative at NIBIB. In 2022 Dr. Goldberg joined NHLBI in the Division of Blood Diseases and Resources (DBDR).
Dr. Goldberg earned her B.S. degree from Brandeis University in Chemistry and Biochemistry, where she gained expertise in protein crystallography. She earned her Ph.D. degree from Georgetown University in materials chemistry where she focused on the crystal growth of secondary explosives. In 2005 she was awarded a Fulbright Fellowship to study crystal engineering, polymorphism, and co-crystallization of small molecules at Ben Gurion University in Be’er Sheva, Israel.
Prior to her NIH position she was a project manager in Global Medical Excellence for AstraZeneca. Dr. Goldberg spent five years as senior scientist and project manager at the Johns Hopkins University Applied Physics Laboratory where she managed multidisciplinary research projects for homeland security. Before that, she was Postdoctoral Research Fellow at the Transportation Security Laboratory in Atlantic City, New Jersey, where she focused on the development of thermal analysis methods for energetic materials as well as the advancement of explosive detection technologies.
Dr. Goldberg is committed to supporting the development of biomedical technologies that enhance public health.